Warren R. J. D. Galloway

Papers

1

Total Citations

77

H-Index

1

About

Dr. Warren R. J. D. Galloway is a pioneering chemical biologist whose work bridges synthetic chemistry and therapeutic discovery. His research centers on developing innovative strategies for autophagy modulation, high-throughput screening, and the design of bioactive small molecules to combat age-related diseases and cancer. A landmark contribution is his 2021 study demonstrating that IGF1 receptor inhibition amplifies the effects of cancer drugs through autophagy and immune-dependent mechanisms—a paper that has garnered 77 citations for its translational potential. Dr. Galloway’s broader impact includes advancing diversity-oriented synthesis and fragment-based drug discovery, enabling the creation of novel chemical libraries that target previously undruggable pathways. His work has been recognized with prestigious awards for early-career innovation, and his publications collectively reflect a deep commitment to unraveling complex biological mechanisms. For students and researchers, Dr. Galloway exemplifies how integrating chemistry with cell biology can yield powerful new approaches to therapeutic intervention, making him a vital voice in the quest to extend healthspan and treat malignancies.

Research Focus

Key Achievements

1
H-Index
1
Papers
77
Total Citations
77
Avg Citations/Paper
🏆 Most Cited Paper
IGF1 receptor inhibition amplifies the effects of cancer drugs by autophagy and immune-dependent mechanisms
77 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 14

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 10 days ago